PURA and myelodysplastic syndrome: In 2001, deletion of the PURA loci was observed in a majority of patients with myeloid disorders, suggesting its involvement in the progression of myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) (Lezon-Geyda et al. 2001).